Human clinical trials of cannabis as medicine
India plans to check out cannabis-based compounds to treat cancer, epilepsy and blood disorders
Saturday, November 24, 2018
Government scientists are preparing for India’s first human clinical trials to test cannabis-based compounds on select diseases in line with what they say is a global resurgence in the medical applications of marijuana derivatives. The researchers have sought regulatory approval for a trial to evaluate these compounds on cancer patients at the Tata Memorial Centre, Mumbai. They are also planning trials in other hospitals for a difficult-to-treat form of epilepsy and a blood disorder called sickle cell anaemia. The Indian Institute of Integrative Medicine (IIIM) in Jammu, a unit of the Council of Scientific and Industrial Research that has cultivated cannabis for research on a one-acre plot, will formulate the derivative compounds for the trials. (See also: Made-in-India drugs to be based on weed soon)
